Pacific Biosciences Of California | PACB - Current Assets


Pacific Biosciences Of California reported $369.52M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agilent USD 4.76B 148M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
General Electric Aerospace USD 40.36B 235M Mar/2026
Illumina USD 2.74B 551M Mar/2026
Myriad Genetics USD 312.8M 19.8M Mar/2026
Pacific Biosciences Of California USD 369.52M 5.54M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Standard Biotools USD 521.45M 67.19M Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Waters USD 3.72B 1.73B Mar/2026